HIMSS: Oracle boosts HIE platform with integration, standards support

Oracle Health Information Exchange has expanded support for federal and global standards, such as the Connect architecture and Integrating the Healthcare Enterprise (IHE) specifications, the company announced last week at HIMSS11 in Orlando, Fla.

Oracle Health Information Exchange is an open-architecture health information exchange (HIE) platform that enables healthcare organizations and government agencies to manage and share health data across networks, according to Oracle, of Redwood Shores, Calif.

The platform provides provides communication, system integration, enterprise master person indexing, consent management and enforcement, access auditing, a clinical data and document repository and record locator services.

The Oracle Health Information Exchange includes:
  • Oracle Health Sciences Information Gateway, which enables secure communications over the internet to safeguard in-transit protected health information (PHI);
  • Oracle Healthcare Master Person Index to provide a single point of reference to information about a patient, clinician or other entity within a healthcare organization or HIE;
  • Oracle Health Sciences Integration Engine, to integrate data across disparate clinical and administrative systems via HL7 messaging.

Also at HIMSS11, Oracle introduced the Oracle Health Sciences Information Manager, supporting technology for EHR and HIE systems that aggregates and manages data, and provides secure access and exchange of PHI. In addition, it handles consent management and auditing for regulatory compliance.

Oracle Health Sciences Information Manager is deployed via an Oracle virtual machine (VM) template, which provides pre-installed and pre-configured software images, according to the company.

The information manager is integrated with Oracle Health Sciences Information Gateway and is included in the latest generation of Oracle HIE. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.